<p><em>PF4V1</em>, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker</p>
Dongyang Li(National Institute of Advanced Industrial Science and Technology)
Cited by 11
Related Papers
Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)
|EClinicalMedicine|2025|9
Molecular Insights into the Inhibition of Lipid Accumulation in Hepatocytes by Unique Extracts of Ashwagandha
|International Journal of Molecular Sciences|2024|3
Comparison of adjuvant treatment for intrahepatic cholangiocarcinoma.
|Journal of Clinical Oncology|2025|1